Daily Archives: February 28, 2018

FDA’s Strategic Policy Roadmap, Part 3 – Improving Health Care, Access Issues and Public Health

Posted on February 28, 2018 by Mark Senak

In the last installment we looked at the first part of the Strategic Roadmap – Addiction which specifically focused on opioids and nicotine. However, the next part of the FDA Strategic Policy Roadmap is less specific and instead is focused … Continue reading →

Posted in FDA Policy | Comments Off on FDA’s Strategic Policy Roadmap, Part 3 – Improving Health Care, Access Issues and Public Health